• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与运动试验相关的晚期冠状动脉支架血栓形成

Late coronary stent thrombosis associated with exercise testing.

作者信息

Parodi Guido, Antoniucci David

机构信息

Division of Cardiology, Careggi Hospital, Florence, Italy.

出版信息

Catheter Cardiovasc Interv. 2004 Apr;61(4):515-7. doi: 10.1002/ccd.10783.

DOI:10.1002/ccd.10783
PMID:15065149
Abstract

We report a case of coronary stent thrombosis that occurred 6 months after the primary stenting of the left anterior descending coronary artery for acute myocardial infarction in a 75-year-old man. The reinfarction occurred the day after the demonstration of persistent optimal result of the percutaneous coronary intervention and immediately after exercise testing. A combined approach of a mechanical thrombus burden reduction by using AngioJet thrombectomy with adjunctive glycoprotein IIb/IIIa antagonist was performed, resulting in the complete removal of filling defects on the angiography.

摘要

我们报告了一例冠状动脉支架血栓形成的病例,该病例发生在一名75岁男性因急性心肌梗死对左前降支冠状动脉进行初次支架置入术后6个月。再梗死发生在经皮冠状动脉介入治疗显示持续最佳效果后的第二天,且在运动试验后立即发生。采用了联合方法,即使用AngioJet血栓切除术减轻机械性血栓负荷并辅助使用糖蛋白IIb/IIIa拮抗剂,结果在血管造影中完全消除了充盈缺损。

相似文献

1
Late coronary stent thrombosis associated with exercise testing.与运动试验相关的晚期冠状动脉支架血栓形成
Catheter Cardiovasc Interv. 2004 Apr;61(4):515-7. doi: 10.1002/ccd.10783.
2
Rheolytic thrombectomy and platelet glycoprotein IIb/IIIa blockade for stent thrombosis.用于支架血栓形成的血栓溶解切除术和血小板糖蛋白IIb/IIIa阻断术
Catheter Cardiovasc Interv. 2002 Sep;57(1):24-30. doi: 10.1002/ccd.10275.
3
Successful trapping of an organized thrombus in a coronary artery aneurysm in myocardial infarction: case report and literature review.成功捕获心肌梗死患者冠状动脉瘤内的机化血栓:病例报告及文献综述
Cardiovasc Revasc Med. 2008 Jan-Mar;9(1):52-5. doi: 10.1016/j.carrev.2007.08.006.
4
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.冠状动脉支架置入术与血小板糖蛋白IIb/IIIa受体阻滞剂的互补临床益处。支架置入术中血小板IIb/IIIa抑制作用评估研究组。
N Engl J Med. 1999 Jul 29;341(5):319-27. doi: 10.1056/NEJM199907293410503.
5
[Glycoprotein IIb/IIIa platelet blockers in acute myocardial infarct treated with primary coronary angioplasty].[糖蛋白IIb/IIIa血小板阻滞剂在直接冠状动脉血管成形术治疗急性心肌梗死中的应用]
Vnitr Lek. 2002 Aug;48(8):736-41.
6
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.急性心肌梗死中血管成形术与支架置入术(无论是否使用阿昔单抗)的比较。
N Engl J Med. 2002 Mar 28;346(13):957-66. doi: 10.1056/NEJMoa013404.
7
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.急性心肌梗死冠状动脉支架置入术中血小板糖蛋白IIb/IIIa抑制作用
N Engl J Med. 2001 Jun 21;344(25):1895-903. doi: 10.1056/NEJM200106213442503.
8
Stenting with intravenous abciximab infusion for the treatment of left main coronary artery thrombosis during coronary angioplasty.
J Invasive Cardiol. 2001 Feb;13(2):107-10.
9
Will blocking the platelet save the diabetic?抑制血小板会拯救糖尿病患者吗?
Circulation. 1999;100(25):2466-8. doi: 10.1161/01.cir.100.25.2466.
10
Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.老年急性心肌梗死患者接受直接冠状动脉介入治疗的结果:来自抑制晚期血管成形术并发症的阿昔单抗与器械对照研究(CADILLAC)试验的结果
Circulation. 2004 Sep 21;110(12):1598-604. doi: 10.1161/01.CIR.0000142862.98817.1F. Epub 2004 Sep 7.

引用本文的文献

1
Early exercise stress testing is safe after primary percutaneous coronary intervention.经皮冠状动脉介入治疗后早期运动负荷试验是安全的。
Eur Heart J Acute Cardiovasc Care. 2012 Jun;1(2):153-7. doi: 10.1177/2048872612445791.
2
Coronary stent thrombosis in the current era: challenges and opportunities for treatment.
Curr Treat Options Cardiovasc Med. 2010 Jan;12(1):46-57. doi: 10.1007/s11936-009-0055-z.